Morgan Stanley Knock-Out MRK/ DE000MB1GLZ1 /
5/22/2024 10:57:58 AM | Chg.+0.06 | Bid11:58:04 AM | Ask11:58:04 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.80EUR | +1.27% | 4.75 Bid Size: 20,000 |
4.76 Ask Size: 20,000 |
MERCK KGAA O.N. | 213.5887 - | 12/31/2078 | Put |
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA